Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2491 to 2505 of 8991 results

  1. Encorafenib with cetuximab and FOLFOX for untreated BRAF V600E mutation-positive metastatic colorectal cancer [ID6734]

    Awaiting development Reference number: GID-TA11961 Expected publication date: TBC

  2. CT hepatic arteriography for patients undergoing percutaneous ablation of primary or secondary liver tumours

    Topic prioritisation

  3. Vacuum Assisted Excision for the removal of breast lesions of uncertain malignant potential

    Topic prioritisation

  4. Lymphatico-venous anastomosis for chronic lymphoedema

    Topic prioritisation

  5. High resolution anoscopy and laser therapy for intraepithelial neoplasia of the anus in high risk or immunocompromised patients

    Topic prioritisation

  6. Transarterial Chemoembolisation for inoperable hepatocellular carcinoma

    Topic prioritisation

  7. The Extraperitoneal approach to left sided colorectal resections ( EXPERTS) Procedure

    Topic prioritisation

  8. Use of a glue or sealant to achieve lung volume reduction in emphysema and lung cancer

    Topic prioritisation

  9. Percutaneous cryotherapy (PCT) for the therapy of primary lung cancer or metastatic lung cancer

    Topic prioritisation

  10. Percutaneous Laser (Photo) Ablation of Liver Tumours

    Topic prioritisation

  11. Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopy, (MT158)

    Topic prioritisation

  12. Magtrace/Sentimag MT599 (MIB263)

    Topic prioritisation

  13. Archimedes for biopsy of suspected lung cancer

    Topic prioritisation

  14. Subcutaneous belimumab for treating systemic lupus erythematosus in children aged 5 to 17 [TSID11828]

    Topic prioritisation

  15. Marstacimab for treating severe haemophilia A or B in people 12 years and over with inhibitors to factor-replacement therapy [TSID12143]

    Awaiting development Reference number: GID-TA11691 Expected publication date: TBC